Keyword: AbbVie

News

China Blocks GSK Finance Head From Leaving Country

18.07.2013 - Chinese authorities investigating the alleged bribery of doctors and officials by GlaxoSmithKline have stopped the drugmaker's head of finance for China, a British citizen, from...

News

Abbott to Buy OptiMedica, Strengthens Medical Device Focus

16.07.2013 - Abbott said on Monday that it would enter the laser cataract surgery business by buying privately held OptiMedica for up to $400 million and in a separate deal would pay $310...

News

Sanofi’s Chris Viehbacher: EU’s Drug Data Stance Threatens Investment

25.06.2013 - The European Medicines Agency's (EMA) decision to release detailed data on drugs once a medicine is approved could discourage critical investment in crisis-hit Europe, Sanofi's...

News

Drug Industry CEOs Plotting More Carve-outs

07.05.2013 - A new generation of drug industry chief executives is stepping up plans to restructure their businesses by divesting slower-growing and maturing operations, opening up new...

News

Court Stops EU Regulator Releasing Drug Company Data

30.04.2013 - Europe's medicines regulator has been stopped from releasing clinical trial data about drugs made by AbbVie and Intermune, following a court ruling favouring the two U.S. companies...

News

AbbVie Delivers on Scorching Humira Drug Sales Growth

26.04.2013 - AbbVie reported slightly better than expected quarterly results on Friday, fueled by surging sales of its Humira treatment for rheumatoid arthritis. Sales of Humira, which accounts...

News

Abbott Devices, Generics Struggle

17.04.2013 - Abbott Laboratories on Wednesday reported higher quarterly earnings after splitting off its branded drug business, and the company said demand was strong for its infant formulas...

News

The Future of Pharma

11.04.2013 - The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...